A year of successful cancer vaccines points to a path forward.


Journal Article (Review)

Results from recent clinical trials of the therapeutic vaccines sipuleucel-T (Dendreon Corp), PROSTVAC-VF-TRICOM (National Cancer Institute/BN ImmunoTherapeutics Inc) and BiovaxID (Biovest International Inc) are highlighted. These data support the further development of such vaccines, and provide guidance for the development of improved agents and protocols for the use of therapeutic vaccination to treat cancer.

Full Text

Duke Authors

Cited Authors

  • Morse, MA; Whelan, M

Published Date

  • February 2010

Published In

Volume / Issue

  • 12 / 1

Start / End Page

  • 11 - 13

PubMed ID

  • 20140811

Pubmed Central ID

  • 20140811

Electronic International Standard Serial Number (EISSN)

  • 2040-3445


  • eng

Conference Location

  • England